Trial Profile
Comparative effectiveness of entecavir and lamivudine on survival of patients with chronic hepatitis B virus infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Dec 2015 New trial record